Title:
PHARMACEUTICAL COMPOSITION FOR PREVENTING, IMPROVING, ALLEVIATING, OR TREATING PULMONARY FIBROSIS, COMPRISING EZETIMIBE AS ACTIVE INGREDIENT
Document Type and Number:
WIPO Patent Application WO/2023/059099
Kind Code:
A1
Abstract:
Provided are: a pharmaceutical composition for preventing, improving, alleviating, or treating pulmonary fibrosis, the composition comprising Ezetimibe or a salt thereof as an active ingredient; a health functional food composition; a method for preventing, improving, alleviating, or treating pulmonary fibrosis using same; and a use thereof. The composition according to one aspect of the present invention contains Ezetimibe and may thus have the effect of preventing, improving, alleviating, or treating pulmonary fibrosis.
More Like This:
Inventors:
KIM SONG YEE (KR)
LEE CHANHO (KR)
BAE SOO HAN (KR)
KIM YOUNG SAM (KR)
LEE JIN GU (KR)
HAN JISU (KR)
LIM BEOM JIN (KR)
KWAK SE HYUN (KR)
SHIN JU HYE (KR)
LEE YU SEOL (KR)
PARK JEONG SU (KR)
LEE CHANHO (KR)
BAE SOO HAN (KR)
KIM YOUNG SAM (KR)
LEE JIN GU (KR)
HAN JISU (KR)
LIM BEOM JIN (KR)
KWAK SE HYUN (KR)
SHIN JU HYE (KR)
LEE YU SEOL (KR)
PARK JEONG SU (KR)
Application Number:
PCT/KR2022/015046
Publication Date:
April 13, 2023
Filing Date:
October 06, 2022
Export Citation:
Assignee:
UNIV YONSEI IACF (KR)
International Classes:
A61K31/397; A23L33/10; A61P11/00; A61P43/00
Foreign References:
| KR102289381B1 | 2021-08-17 | |||
| KR101845862B1 | 2018-04-06 | |||
| JP2017203013A | 2017-11-16 | |||
| JP2018184381A | 2018-11-22 | |||
| KR102001437B1 | 2019-07-19 |
Attorney, Agent or Firm:
Y.P.LEE, MOCK & PARTNERS (KR)
Download PDF: